Form 4: Pressure BioSciences Director Acquires Shares as Interest Payment

Director Alexander V. Lazarev acquired 3,755 shares of Pressure BioSciences Inc. as interest on convertible preferred stock.

Summary

• On March 27, 2024, Alexander V. Lazarev, a director of Pressure BioSciences Inc., acquired 3,755 shares of common stock.
• The shares were acquired at a price of $0.16 per share.
• This acquisition was due to interest paid in shares of common stock on convertible preferred stock.
• Following the transaction, Lazarev directly owns 18,537 shares of Pressure BioSciences Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. The acquisition of shares by a director could be seen as a slightly positive sign, but it's a small amount related to interest payment.

Positives

• A director increasing their stake in the company can be seen as a positive signal.

Industry Context

This is a routine disclosure of insider trading activity. It is important to monitor insider transactions as they can provide insights into management's view of the company's prospects.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it slightly increases the number of outstanding shares.

Key Dates

Keywords

Pressure BioSciences Inc, PBIO, Alexander V. Lazarev, Director, Share Acquisition, Convertible Preferred Stock, Interest Payment, Common Stock, Beneficial Ownership, SEC Form 4